EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Cystic fibrosis‐related diabetes develops from a combination of insulin secretion defects and insulin resistance

Marie-Ève Bolduc iD, Kathryn J Potter, Maxime Olmos, Anne Bonhoure, Adèle Coriati, Laure Alexandre-Heymann, François Tremblay, Annick Lavoie, Maité Carricart, Peter A Senior, Valérie Boudreau, Rémi Rabasa-Lhoret iD

Diabetes, Obesity and Metabolism · 2024-10 · 26 (10) · 4744-4752

DOI: 10.1111/dom.15844 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Diabetes, Obesity and Metabolism, online erschienen am 09.08.2024. Verfasst von Marie-Ève Bolduc und 11 weiteren Autor:innen. Beteiligte Einrichtung: Montreal Clinical Research Institute (IRCM), Montréal, Québec, Canada. Hauptthemen laut MEDLINE: Cystic Fibrosis, Insulin Resistance, Glucose Tolerance Test, Insulin Secretion. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Canadian Cystic Fibrosis Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aim

The relative contributions of insulin secretory defects and possible additional contribution of insulin resistance for the development of cystic fibrosis (CF)‐related diabetes (CFRD) are poorly understood. We aimed to (a) determine which indices of insulin resistance predict progression to CFRD, and (b) to model the relative contributions of insulin secretory function and insulin resistance to predict the risk of CFRD. Materials and Methods Three hundred and three individuals living with CF underwent a 2‐h oral glucose tolerance test with blood sampling every 30 min at 12–24‐month intervals until they developed CFRD or until the end of follow‐up (up to 15 years). Indices of insulin resistance (e.g. Stumvoll) and insulin secretion were calculated from oral glucose tolerance test glucose and insulin measurements. CFRD‐free survival was assessed by survival analysis.

Results

Estimated insulin resistance showed associations with glucose homeostasis and risk of progression to CFRD. The CFRD‐free survival was significantly different between quartiles of insulin resistance ( p < 0.0001). When patients were subdivided according to both insulin resistance and insulin secretion (insulinogenic index), CFRD‐free survival was significantly lower in those with combined lowest insulin secretion and highest insulin resistance (Stumvoll) indices (hazard ratio: 11.2; p < 0.0001). There was no significant difference when the same analysis was performed for the nine other indices.

Conclusions

Insulin resistance is correlated with glucose homeostasis and the risk of progression to CFRD. Patients combining low insulin secretion and high insulin resistance had the greatest odds of developing CFRD over a 15‐year period.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cystic FibrosisInsulin ResistanceGlucose Tolerance TestInsulin SecretionInsulinDisease ProgressionHumansMaleFemaleAdultAdolescentDiabetes MellitusBlood GlucoseYoung AdultChild

Stichwörter der Autor:innen

database researchinsulin resistanceinsulin secretionobservational studyreal‐world evidence

Substanzen

InsulinBlood Glucose

Autor:innen und Institutionen

  • Montreal Clinical Research Institute (IRCM), Montréal, Québec, Canada.
  • Department of Nutrition, Faculty of Medicine, Université de Montréal, Montréal, Québec, Canada.
  • Research Centre of Hôpital du Sacré-Cœur de Montréal, Centre intégré universitaire de santé et de services sociaux (CIUSSS) du Nord-de-l'Île-de-Montréal, Montréal, Québec, Canada.
  • Department of Medicine, Faculty of Medicine, Université de Montréal, Montréal, Québec, Canada.
  • Cystic Fibrosis Clinic, Centre hospitalier de l'Université de Montréal (CHUM), Montréal, Québec, Canada.
  • Alberta Diabetes Institute, University of Alberta, Edmonton, Alberta, Canada.

ORCID-Profile: Marie-Ève Bolduc, Rémi Rabasa-Lhoret

Förderung

  • Canadian Cystic Fibrosis Foundation

Zitieren

APA

Bolduc, M. È., Potter, K. J., Olmos, M., Bonhoure, A., Coriati, A., Alexandre-Heymann, L., Tremblay, F., Lavoie, A., Carricart, M., Senior, P. A., Boudreau, V., & Rabasa-Lhoret, R. (2024). Cystic fibrosis‐related diabetes develops from a combination of insulin secretion defects and insulin resistance. Diabetes, Obesity and Metabolism, 26(10), 4744-4752. https://doi.org/10.1111/dom.15844

Vancouver

Bolduc MÈ, Potter KJ, Olmos M, Bonhoure A, Coriati A, Alexandre-Heymann L, et al. Cystic fibrosis‐related diabetes develops from a combination of insulin secretion defects and insulin resistance. Diabetes, Obesity and Metabolism. 2024;26(10):4744-4752. doi:10.1111/dom.15844

BibTeX
@article{Bolduc2024,
  author = {Bolduc, Marie-Ève and Potter, Kathryn J and Olmos, Maxime and Bonhoure, Anne and Coriati, Adèle and Alexandre-Heymann, Laure and Tremblay, François and Lavoie, Annick and Carricart, Maité and Senior, Peter A and Boudreau, Valérie and Rabasa-Lhoret, Rémi},
  title = {Cystic fibrosis‐related diabetes develops from a combination of insulin secretion defects and insulin resistance},
  journal = {Diabetes, Obesity and Metabolism},
  year = {2024},
  volume = {26},
  number = {10},
  pages = {4744--4752},
  doi = {10.1111/dom.15844}
}
Kostenlos starten →